相关产品推荐更多 >

MIER2抗体MIER2兔多抗抗体MIER2_HUMAN antibody抗体MIER2 Antibody, HRP conjugated抗体
¥880
OSBP抗体OSBP兔多抗抗体Oxysterol-binding protein 1 antibody抗体OSBP Antibody, HRP conjugated抗体
¥880
RTCA抗体RTCA兔多抗抗体RTC domain-containing protein 1 antibody抗体RTCA Antibody, Biotin conjugated抗体
¥880
NR3C1抗体NR3C1兔多抗抗体member 1 (glucocorticoid receptor) antibody抗体NR3C1 Antibody, FITC conjugated抗体
¥880
YWHAB抗体YWHAB兔多抗抗体YWHAZ antibody抗体YWHAB Antibody, HRP conjugated抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Gallus gallus Tubulin beta-1 chain protein (1-439AA)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
Non-conjugated
- 适应物种:
Gallus gallus
- 保质期:
6个月
- 抗原来源:
Gallus gallus
- 目录编号:
P09203
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA
- 浓度:
>95%,Protein G purified
- 靶点:
/
- 抗体英文名:
Tubulin beta-1 chain Antibody
- 抗体名:
antibody;Tubulin beta-1 chain antibody;Beta-tubulin class-I antibody
- 规格:
100μg/50μg/20μg
| 规格: | 100μg | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μg | 产品价格: | ¥880.0 |
| 规格: | 20μg | 产品价格: | ¥440.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
功能
Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha-chain.风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验抗子宫内膜抗体(endomethal antibody,EMAb)检测
子宫内膜抗体(endomethal antibody,EMAb)是子宫内膜异位病患者受到异位内膜的刺激,或经血逆流等因素导致免疫应答紊乱产生的一种自身抗体,并与子宫内膜中靶抗原结合,在补体参与下,引起子宫内膜免疫病理损伤,影响孕卵着床,也容易发生早期流产。目前检测EMAb的方法有间接免疫荧光法(1FT)、双向免疫扩散法(1D)、间接血凝法(PHA)及ELISA法等。IFF法需刮取子宫内膜制备抗原片,并需一定设备
cells at 3000 X g. Resuspend in 200 mls Solution A. Repeat wash. Pellet cells as above and resuspend in 4 mls Solution A. Reserve 2 mls of the cell suspension. Spheroplast the remaining 2 ml of the cell suspension by addition of beta
双特异抗体(Bispecific antibody)的简介和制作方法
of this progress, the efficacy of monoclonal antibodies for cancer treatment is still limited, leaving great potential for further improvements. One class of antibody derivatives with the promise of enhanced potency for cancer treatment are bispecific antibodies.二
技术资料暂无技术资料 索取技术资料





